Press Release: Mapmygenome India Expands Team, Starts Operations in Delhi-NCR
Hyderabad & New Delhi, India, May 27, 2015: Mapmygenome India announced the start of operations in Delhi-NCR beginning June 1, 2015 and an expanded team including changes in top management. The new office premises are at Investopad, Gurgaon. This is the first team expansion following a Pre Series A round of USD 1.1 Million funding in March 2015.
The strategic move to start operations in Delhi-NCR aims to close the gap by fulfilling an existing need for genomic testing and genetic counselling services in North India. The Delhi team will focus on more personalized and efficient genomics services there. Access to North India markets will also help in targeted efforts for raising awareness about genomics testing.
The new team in Delhi comprises Chief Medical Officer – Dr. Naveen Talwar, VP Business Development (Delhi) – Dr. Jaishree Srinivasan, senior genetic counselors, admin, and sales personnel. Additions to Hyderabad team include Sr. VP Operations – Wing Commander (Dr.) M.K. Bose, VP Business Development & Scientific Communications – Dr. Nita Sachan, and marketing team.
Ms. Anu Acharya, CEO of Mapmygenome, said, “A new office in Delhi-NCR is a key strategic move for us. With two offices and an expanded team, we are sure to see an exponential increase in sales and performance.”
Mapmygenome India offers a variety of services in the domains of personal genomics, molecular diagnostics, DNA forensics, and brain wellness. Their products and services can be purchased from their stores online (www.mapmygenome.in), through their e-commerce partners such as SnapDeal.com or amazon.in, or from their wide network of diagnostics and hospital partners.
As pioneers of personal genomics in India, they created a new market in the country for predictive tests with their flagship brand Genomepatri™ in April 2013. In February 2014, the Government of Karnataka awarded them the Bio Excellence award “Emerging Company of the Year”. In March 2015, they raised a US $ 1.1 million Pre Series A rounding of funding from multiple sources.
Personal genomics products provide insights into the genetic basis of individuals’ health, including traits, lifestyle, drug responses, inherited conditions, and diseases. By combining genetic report and health history with genetic counseling, Mapmygenome provides actionable steps for individuals and their physicians towards a healthier life.
Molecular diagnostics are tests recommended by doctors for cancer, cardiovascular, neuromuscular, and other key conditions.
Mapmygenome also offers molecular tests for TB and other infectious diseases that increase accuracy at very low costs.
DNA Forensics include maternity, paternity, sibling, and other identification tests.
Brain wellness includes a series of assessments for improving emotional and cognitive efficacy, for assessing leadership skills, and more.
For more information, visit www.mapmygenome.in.
Dr. Naveen Talwar